← Back to patent-cliff list
CAS 211617-68-4
4-((triisopropylsilyl)oxy)benzaldehyde
Codes：SAFI-008
Application context (from source-drug indications)
帕金森病甲磺酸沙非胺疼痛甲磺酸沙非胺药物性运动障碍甲磺酸沙非胺肝功能衰退甲磺酸沙非胺多系统萎缩甲磺酸沙非胺肾功能不全甲磺酸沙非胺
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 甲磺酸沙非胺Safinamide Mesylate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(((9H-fluoren-9-yl)methoxy)carbonyl)-L-alanine→(S)-(9H-fluoren-9-yl)methyl (1-(methylamino)-1-oxopropan-2-yl)carbamate→(S)-2-amino-N-methylpropanamide→4-((triisopropylsilyl)oxy)benzaldehyde→(S,E)-N-methyl-2-((4-((triisopropylsilyl)oxy)benzylidene)amino)propanamide→(S)-N-methyl-2-((4-((triisopropylsilyl)oxy)benzyl)amino)propanamide→(S)-2-((4-hydroxybenzyl)amino)-N-methylpropanamide→(3-fluorophenyl)methanol→(S)-2-((4-((3-fluorobenzyl)oxy)benzyl)amino)-N-methylpropanamide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.